GW Pharmaceuticals Unveils German Pricing Decision on Sativex
GW Pharmaceuticals unveils German pricing decision on Sativex
Filed under: drug rehab treatment options
In June 2012 the German Federal Joint Committee (G-BA), the national reimbursement authority, determined that Sativex – a plant-derived cannabinoid prescription drug – provided added benefit over current treatment options in the treatment of spasticity …
Read more on IFA Magazine
BUSINESS: Half of 1200 job cuts at AstraZeneca will be layoffs
Filed under: drug rehab treatment options
Soriot is charged with bolstering the firm's weakened developmental pipeline to compensate for billions in lost revenues following the loss of patent protections on a string of the company's top-selling drugs. He plans to refocus the firm on research …
Read more on Delmarva Now
Addex Therapeutics Awarded MM Grant from The Michael J. Fox Foundation …
Filed under: drug rehab treatment options
Existing treatment options are limited and insufficient to address patients' medical needs. Patients are faced with a lose-lose … to the treatment of PD-LID. Ultimately, we hope to see dipraglurant become the first drug to alleviate all PD-LID …
Read more on PharmaLive (press release) (subscription)
This Biotech Leader Pays a Rare 8.3% Yield
Filed under: drug rehab treatment options
At the same time, the drugs target cancer cells more precisely, which can be a more-effective way to treat this malady than by using strong drugs that also kill a lot of healthy cells. In fact, two of PDL's Top Three selling drugs target cancer. They …
Read more on Money Morning